Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer-Reference-Cited by-同舟云学术

Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer

Published:2021-09-15 Issue:12 Volume:18 Page:739-762
ISSN:1759-4812
Container-title:Nature Reviews Urology
language:en
Short-container-title:Nat Rev Urol

Author:

Devos Gaëtan^ORCID,Devlies Wout^ORCID,De Meerleer Gert,Baldewijns Marcella,Gevaert Thomas,Moris Lisa,Milonas Daimantas,Van Poppel Hendrik^ORCID,Berghen Charlien,Everaerts Wouter,Claessens Frank^ORCID,Joniau Steven^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

https://www.nature.com/articles/s41585-021-00514-9.pdf

Reference225 articles.

1. Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).

2. Cooperberg, M. R., Broering, J. M. & Carroll, P. R. Time trends and local variation in primary treatment of localized prostate cancer. J. Clin. Oncol. 28, 1117–1123 (2010).

3. Zelic, R. et al. Predicting prostate cancer death with different pretreatment risk stratification tools: a head-to-head comparison in a nationwide cohort study. Eur. Urol. 77, 180–188 (2020).

4. Joniau, S. et al. Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional study. Eur. Urol. 67, 157–164 (2015).

5. D’Amico, A. V. et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280, 969–974 (1998).

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amiloride Sensitizes Prostate Cancer Cells to the Reversible Tyrosine Kinase Inhibitor Lapatinib by Modulating ERBB3 Subcellular Localization;2024-08-30

2. Development of preoperative nomograms to predict the risk of overall and multifocal positive surgical margin after radical prostatectomy;Cancer Imaging;2024-08-08

3. Synergistic Strategies for Castration-Resistant Prostate Cancer: Targeting AR-V7, Exploring Natural Compounds, and Optimizing FDA-Approved Therapies;Cancers;2024-08-06

4. Targeting S6K/NFκB/SQSTM1/Polθ signaling to suppress radiation resistance in prostate cancer;Cancer Letters;2024-08

5. Solvent and monomer regulation synthesis of core-shelled magnetic β-cyclodextrin microporous organic network for efficient extraction of estrogens in biological samples prior to HPLC analysis;Journal of Chromatography A;2024-08